{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:47:01Z","timestamp":1788468421301,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1038\/s41390-019-0716-x","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T16:03:22Z","timestamp":1575907402000},"page":"991-997","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Role of dopamine and selective dopamine receptor agonists on mouse ductus arteriosus tone and responsiveness"],"prefix":"10.1038","volume":"87","author":[{"given":"Stacey L.","family":"Crockett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Boatwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Yarboro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney D.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine L.","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Segar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"716_CR1","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.1542\/neo.19-7-e394","volume":"19","author":"M Gillam-Krakauer","year":"2018","unstructured":"Gillam-Krakauer, M. & Reese, J. Diagnosis and management of patent ductus arteriosus. Neoreviews 19, e394\u2013e402 (2018).","journal-title":"Neoreviews"},{"key":"716_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jpeds.2018.09.012","volume":"205","author":"RI Clyman","year":"2019","unstructured":"Clyman, R. I. et al. PDA-TOLERATE Trial: an exploratory randomized controlled trial of treatment of moderate-to-large patent ductus arteriosus at 1 week of age. J. Pediatr. 205, 41\u201348.e46 (2019).","journal-title":"J. Pediatr."},{"key":"716_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00003246-200202000-00013","volume":"30","author":"CL Shaffer","year":"2002","unstructured":"Shaffer, C. L. et al. Effect of age and birth weight on indomethacin pharmacodynamics in neonates treated for patent ductus arteriosus. Crit. Care Med. 30, 343\u2013348 (2002).","journal-title":"Crit. Care Med."},{"key":"716_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1542\/peds.112.2.345","volume":"112","author":"J Lee","year":"2003","unstructured":"Lee, J. et al. Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants. Pediatrics 112, 345\u2013350 (2003).","journal-title":"Pediatrics"},{"key":"716_CR5","doi-asserted-by":"publisher","unstructured":"Barrington K. J., Brion L. P. Dopamine versus no treatment to prevent renal dysfunction in indomethacin\u2010treated preterm newborn infants. Cochrane Database Syst. Rev. 2002, CD003213. https:\/\/doi.org\/10.1002\/14651858.CD003213.","DOI":"10.1002\/14651858.CD003213"},{"key":"716_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/01.PCC.0000194046.47306.FB","volume":"7","author":"JM Costello","year":"2006","unstructured":"Costello, J. M. et al. Initial experience with fenoldopam after cardiac surgery in neonates with an insufficient response to conventional diuretics. Pediatr. Crit. Care Med. 7, 28\u201333 (2006).","journal-title":"Pediatr. Crit. Care Med."},{"key":"716_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1053\/j.jvca.2012.01.038","volume":"26","author":"A Zangrillo","year":"2012","unstructured":"Zangrillo, A. et al. Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials. J. Cardiothorac. Vasc. Anesth. 26, 407\u2013413 (2012).","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"716_CR8","first-page":"R868","volume":"263","author":"JL Segar","year":"1992","unstructured":"Segar, J. L., Smith, F. G., Guillery, E. N., Jose, P. A. & Robillard, J. E. Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep. Am. J. Physiol. 263, R868\u2013R873 (1992).","journal-title":"Am. J. Physiol."},{"key":"716_CR9","doi-asserted-by":"publisher","first-page":"H572","DOI":"10.1152\/ajpheart.00822.2015","volume":"311","author":"CW Hooper","year":"2016","unstructured":"Hooper, C. W. et al. Selective serotonin reuptake inhibitor exposure constricts the mouse ductus arteriosus in utero. Am. J. Physiol. Heart Circ. Physiol. 311, H572\u2013H581 (2016).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"716_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.prostaglandins.2008.11.001","volume":"88","author":"J Reese","year":"2009","unstructured":"Reese, J. et al. Regulation of the fetal mouse ductus arteriosus is dependent on interaction of nitric oxide and COX enzymes in the ductal wall. Prostaglandins Other Lipid Mediat. 88, 89\u201396 (2009).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"716_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.yjmcc.2013.02.010","volume":"59","author":"RB Cotton","year":"2013","unstructured":"Cotton, R. B. et al. Cimetidine-associated patent ductus arteriosus is mediated via a cytochrome P450 mechanism independent of H2 receptor antagonism. J. Mol. Cell Cardiol. 59, 86\u201394 (2013).","journal-title":"J. Mol. Cell Cardiol."},{"key":"716_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.yjmcc.2014.01.016","volume":"69","author":"ER Pfaltzgraff","year":"2014","unstructured":"Pfaltzgraff, E. R. et al. Embryonic domains of the aorta derived from diverse origins exhibit distinct properties that converge into a common phenotype in the adult. J. Mol. Cell Cardiol. 69, 88\u201396 (2014).","journal-title":"J. Mol. Cell Cardiol."},{"key":"716_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1152\/physiolgenomics.00171.2013","volume":"46","author":"EL Shelton","year":"2014","unstructured":"Shelton, E. L. et al. Transcriptional profiling reveals ductus arteriosus-specific genes that regulate vascular tone. Physiol. Genomics 46, 457\u2013466 (2014).","journal-title":"Physiol. Genomics"},{"key":"716_CR14","doi-asserted-by":"publisher","first-page":"H732","DOI":"10.1152\/ajpheart.00838.2013","volume":"307","author":"MM Vucovich","year":"2014","unstructured":"Vucovich, M. M. et al. Aminoglycoside-mediated relaxation of the ductus arteriosus in sepsis-associated PDA. Am. J. Physiol. Heart Circ. Physiol. 307, H732\u2013H740 (2014).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"716_CR15","doi-asserted-by":"publisher","first-page":"107392","DOI":"10.1016\/j.pharmthera.2019.07.003","volume":"9","author":"C Bucolo","year":"2019","unstructured":"Bucolo, C., Leggio, G. M., Drago, F. & Salomone Dopamine outside the brain: the eye, cardiovascular system and endocrine pancreas. Pharmacol. Therapeutics 9, 107392 (2019).","journal-title":"Pharmacol. Therapeutics"},{"key":"716_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0014-2999(82)90352-1","volume":"81","author":"NB Shepperson","year":"1982","unstructured":"Shepperson, N. B., Duval, N. & Langer, S. Z. Dopamine decreases mesenteric blood flow in the anaesthetised dog through the stimulation of postsynaptic alpha 2-adrenoceptors. Eur. J. Pharm. 81, 627\u2013635 (1982).","journal-title":"Eur. J. Pharm."},{"key":"716_CR17","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/j.1476-5381.1989.tb12036.x","volume":"97","author":"AD Hughes","year":"1989","unstructured":"Hughes, A. D. & Sever, P. S. The action of dopamine and vascular dopamine (DA1) receptor agonists on human isolated subcutaneous and omental small arteries. Br. J. Pharm. 97, 950\u2013956 (1989).","journal-title":"Br. J. Pharm."},{"key":"716_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00005344-198801000-00018","volume":"11","author":"JD Kohli","year":"1988","unstructured":"Kohli, J. D., Glock, D. & Goldberg, L. I. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog. J. Cardiovasc. Pharm. 11, 123\u2013126 (1988).","journal-title":"J. Cardiovasc. Pharm."},{"key":"716_CR19","first-page":"S8","volume":"8","author":"JZ Stoller","year":"2012","unstructured":"Stoller, J. Z., Demauro, S. B., Dagle, J. M. & Reese, J. Current perspectives on pathobiology of the ductus arteriosus. J. Clin. Exp. Cardiol. 8, S8\u2013001 (2012).","journal-title":"J. Clin. Exp. Cardiol."},{"key":"716_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1055\/s-0033-1361933","volume":"31","author":"EM Hsieh","year":"2014","unstructured":"Hsieh, E. M. et al. Medication use in the neonatal intensive care unit. Am. J. Perinatol. 31, 811\u2013821 (2014).","journal-title":"Am. J. Perinatol."},{"key":"716_CR21","first-page":"209","volume":"5","author":"I Seri","year":"1984","unstructured":"Seri, I., Tulassay, T., Kiszel, J. & Csomor, S. The use of dopamine for the prevention of the renal side effects of indomethacin in premature infants with patent ductus arteriosus. Int. J. Pediatr. Nephrol. 5, 209\u2013214 (1984).","journal-title":"Int. J. Pediatr. Nephrol."},{"key":"716_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00134-003-2032-4","volume":"30","author":"AJ Johnston","year":"2004","unstructured":"Johnston, A. J. et al. Pharmacokinetics and pharmacodynamics of dopamine and norepinephrine in critically ill head-injured patients. Intensive Care Med. 30, 45\u201350 (2004).","journal-title":"Intensive Care Med."},{"key":"716_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/pr.2012.58","volume":"72","author":"JX Chen","year":"2012","unstructured":"Chen, J. X. et al. Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus. Pediatr. Res. 72, 122\u2013128 (2012).","journal-title":"Pediatr. Res."},{"key":"716_CR24","doi-asserted-by":"publisher","first-page":"E1861","DOI":"10.3390\/ijms19071861","volume":"19","author":"Y-C Hung","year":"2018","unstructured":"Hung, Y.-C., Yeh, J.-L. & Hsu, J.-H. Molecular mechanisms for regulating postnatal ductus arteriosus closure. Int. J. Mol. Sci. 19, E1861 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"716_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1067\/mpd.2002.123100","volume":"140","author":"JM Liet","year":"2002","unstructured":"Liet, J. M. et al. Dopamine effects on pulmonary artery pressure in hypotensive preterm infants with patent ductus arteriosus. J. Pediatr. 140, 373\u2013375 (2002).","journal-title":"J. Pediatr."},{"key":"716_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0022-3476(05)81914-6","volume":"121","author":"CA Fajardo","year":"1992","unstructured":"Fajardo, C. A., Whyte, R. K. & Steele, B. T. Effect of dopamine on failure of indomethacin to close the patent ductus arteriosus. J. Pediatr. 121, 771\u2013775 (1992).","journal-title":"J. Pediatr."},{"key":"716_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bph.12906","volume":"172","author":"JM Beaulieu","year":"2015","unstructured":"Beaulieu, J. M., Espinoza, S. & Gainetdinov, R. R. Dopamine receptors\u2014IUPHAR Review 13. Br. J. Pharm. 172, 1\u201323 (2015).","journal-title":"Br. J. Pharm."},{"key":"716_CR28","first-page":"119","volume":"26","author":"AD Hughes","year":"1989","unstructured":"Hughes, A. D. & Sever, P. S. Action of fenoldopam, a selective dopamine (DA1) receptor agonist, on isolated human arteries. Blood Vessels 26, 119\u2013127 (1989).","journal-title":"Blood Vessels"},{"key":"716_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ddr.430030402","volume":"3","author":"MF Lokhandwala","year":"1983","unstructured":"Lokhandwala, M. F. & Barrett, R. J. Dopamine receptor agonists in cardiovascular therapy. Drug Dev. Res. 3, 299\u2013310 (1983).","journal-title":"Drug Dev. Res."},{"key":"716_CR30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1016-8478(23)13562-X","volume":"9","author":"MO Kim","year":"1999","unstructured":"Kim, M. O. et al. Localization of dopamine D1 and D2 receptor mRNAs in the rat systemic and pulmonary vasculatures. Mol. Cells 9, 417\u2013421 (1999).","journal-title":"Mol. Cells"},{"key":"716_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1081\/CEH-100100077","volume":"22","author":"F Amenta","year":"2000","unstructured":"Amenta, F. et al. Localization of dopamine receptor subtypes in systemic arteries. Clin. Exp. Hypertens. 22, 277\u2013288 (2000).","journal-title":"Clin. Exp. Hypertens."},{"key":"716_CR32","first-page":"187","volume":"236","author":"RW Lappe","year":"1986","unstructured":"Lappe, R. W., Todt, J. A. & Wendt, R. L. Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats. J. Pharm. Exp. Ther. 236, 187\u2013191 (1986).","journal-title":"J. Pharm. Exp. Ther."},{"key":"716_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2253-8-6","volume":"8","author":"GB Hammer","year":"2008","unstructured":"Hammer, G. B., Verghese, S. T., Drover, D. R., Yaster, M. & Tobin, J. R. Pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients. BMC Anesthesiol. 8, 6 (2008).","journal-title":"BMC Anesthesiol."},{"key":"716_CR34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1213\/00000539-200302000-00044","volume":"96","author":"N Sato","year":"2003","unstructured":"Sato, N. et al. The vasodilatory effects of hydralazine, nicardipine, nitroglycerin, and fenoldopam in the human umbilical artery. Anesth. Analg. 96, 539\u2013544 (2003).","journal-title":"Anesth. Analg."},{"key":"716_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1161\/01.HYP.5.2.226","volume":"5","author":"AA Taylor","year":"1983","unstructured":"Taylor, A. A. et al. Activation of peripheral dopamine presynaptic receptors lowers blood pressure and heart rate in dogs. Hypertension 5, 226\u2013234 (1983).","journal-title":"Hypertension"},{"key":"716_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/01.HYP.38.3.303","volume":"38","author":"XX Li","year":"2001","unstructured":"Li, X. X. et al. Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension 38, 303\u2013308 (2001).","journal-title":"Hypertension"},{"key":"716_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12028-008-9143-2","volume":"10","author":"GJ Pyne-Geithman","year":"2009","unstructured":"Pyne-Geithman, G. J., Caudell, D. N., Cooper, M., Clark, J. F. & Shutter, L. A. Dopamine D2-receptor-mediated increase in vascular and endothelial NOS activity ameliorates cerebral vasospasm after subarachnoid hemorrhage in vitro. Neurocrit. Care 10, 225\u2013231 (2009).","journal-title":"Neurocrit. Care"},{"key":"716_CR38","doi-asserted-by":"publisher","first-page":"R1660","DOI":"10.1152\/ajpregu.00147.2009","volume":"297","author":"CS Escano","year":"2009","unstructured":"Escano, C. S. et al. Renal dopaminergic defect in C57Bl\/6J mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297, R1660\u2013R1669 (2009).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"716_CR39","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1681\/ASN.V281265","volume":"2","author":"PA Jose","year":"1992","unstructured":"Jose, P. A. et al. The renal dopamine receptors. J. Am. Soc. Nephrol. 2, 1265\u20131278 (1992).","journal-title":"J. Am. Soc. Nephrol."},{"key":"716_CR40","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1055\/s-0029-1223288","volume":"26","author":"SE Yoder","year":"2009","unstructured":"Yoder, S. E. & Yoder, B. A. An evaluation of off-label fenoldopam use in the neonatal intensive care unit. Am. J. Perinatol. 26, 745\u2013750 (2009).","journal-title":"Am. J. Perinatol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0716-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0716-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0716-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T09:32:33Z","timestamp":1722159153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0716-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["716"],"URL":"https:\/\/doi.org\/10.1038\/s41390-019-0716-x","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"assertion":[{"value":"24 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}